← SynDRA
ETIDOCAINE
SynDRA canonical compound SYN0000433 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · OTC |
| Primary target(s) | A1BG |
| Mechanism of action | sodium channel blocker |
| Indication | anesthetic |
| Disease area | neurology/psychiatry |
All known targets
- SCN2A
- SCN4A
- SCN5A
- A1BG
- KCNK3
- SCN10A
- SCN11A
- SCN1A
- SCN3A
- SCN7A
- SCN8A
- SCN9A
Mechanisms of action (all sources)
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
- SCN10A BLOCKER
- sodium channel blocker
Drug classes
- Anesthetics
- Anesthetics, Local
- Central Nervous System Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- N01B · ANESTHETICS, LOCAL
Cross-references
Synonyms
- etidocaine hydrochloride
- etidocaine HCl
- Etidocaina
- W-19053 FREE BASE
- W-19053 [AS HYDROCHLORIDE]
- Duranest
- N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
- Etidocainum
- 2-(Ethylpropylamino)-2',6'-butyroxylidide
- I6CQM0F31V
- (+-)-N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butanamide
- CHEBI:4904
- DTXCID703027
- Duranest (as hydrochloride)
- Duranest [as hydrochloride]
- N-(2,6-dimethylphenyl)-2-(ethyl-propylamino)butanamide
- N-(2,6-dimethylphenyl)-2-(ethyl(propyl)amino)butanamide
- RefChem:388963
- N01BB07
- W19053
- Etidocaine, (+)-
- Etidocaine, (-)-
- (+-)-2-(Ethylpropylamino)-2',6'-butyroxylidide
- BRN 2741181
- K9D2CE52PU
- Y83XVY9AQ8
- Etidocainum [INN-Latin]
- Etidocaina [INN-Spanish]
- EINECS 253-143-8
- UNII-I6CQM0F31V
- UNII-K9D2CE52PU
- UNII-Y83XVY9AQ8
- Etidocaine [USAN:INN:BAN]
- NCGC00183654-01
- 2',6'-BUTYROXYLIDIDE, 2-(ETHYLPROPYLAMINO)-
- LEVO-ETIDOCAINE
- DEXTRO-ETIDOCAINE
- ETIDOCAINE [MI]
Look up ETIDOCAINE in the interactive SynDRA portal →